why choose us

First received: January 20, 2023

Clinical Trial: CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission

Study Status: Completed

Recruit Status: RECRUITING

Condition: B Acute Lymphoblastic Leukemia

Study Type: INTERVENTIONAL


Official Title: A Pilot Study of CD19-Specific Car T Cells as Consolidation for Older Adults With Acute Lymphoblastic Leukemia in First Remission

Brief Summary: This phase I trial tests the safety, side effects, and best dose of autologous anti-CD19 CAR-expressing T lymphocytes (CD19-CAR T cells) in older adults with B-cell acute lymphoblastic leukemia.Chimeric antigen receptor (CAR) T-cell therapy is a type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells.T cells are taken from a patient's blood.Then the gene for a special receptor that binds to a certain protein on the…

Read more